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A reusable robust radio frequency (RF) biosensor with a rectangular meandered line (RML) resonator on a
gallium arsenide substrate by integrated passive device (IPD) technology was designed, fabricated and
tested to enable the real-time identiﬁcation of the glucose level in human serum. The air-bridge structure
fabricated by an IPD technology was applied to the RML resonator to improve its sensitivity by increasing
the magnitude of the return loss (S21). The resonance behaviour, based on S21 characteristics of the
biosensor, was analysed at 9.20 GHz with human serum containing different glucose concentration
ranging from 148–268 mg dl1, 105–225 mg dl1 and at a deionised (D) water glucose concentration in
the range of 25– 500 mg dl1 for seven different samples. A calibration analysis was performed for the
human serum from two different subjects and for D-glucose at a response time of 60 s; the reproduci-
bility, the minimum shift in resonance frequency and the long-term stability of the signal were in-
vestigated. The feature characteristics based on the resonance concept after the use of serum as an
analyte are modelled as an inductor, capacitor and resistor. The ﬁndings support the development of
resonance-based sensing with an excellent sensitivity of 1.08 MHz per 1 mg dl1, a detection limit of
8.01 mg dl1, and a limit of quantisation of 24.30 mg dl1.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Diabetes mellitus is a disease that often causes difﬁculties in the
maintenance of a normal level of blood glucose in a patient, mainly
because either insufﬁcient insulin is produced by the beta cells in the
pancreas, or the body is unable to effectively utilise that insulin
(Vaddiraju et al., 2010). The American Diabetes Association re-
commends a fasting plasma glucose level of 70–130mg dl1 for a
normal person. If the glucose level is between 60–68mg dl1, then
the condition is called hypoglycaemia. If the glucose level is above
240mg dl1, it is called hyperglycaemia. Both types of diabetes are a
result of the dysregulation of the glucose level in the human body. A
minimally invasive glucose sensor helps to monitor the glucose level
and helps in the early diagnostic phase for the patients.
Currently, there are many invasive techniques used for the
detection of glucose levels in the serum as well as various devices
designed based on sensing techniques such as electroimpedance
spectroscopy, enzyme oxidation, time domain reﬂectometer, and
surface plasma resonance, potentiometic, voltammetric andB.V. This is an open access article u
ioraj@gmail.com (R. Dhakal).amperometric techniques (Liu et al., 2013; Yonemori et al., 2009;
Yan et al., 2011; Chou et al., 2013; Mahdi et al., 2012). Among these
techniques, enzyme oxidation methods are the most reliable;
however, these methods are invasive, have a serious disadvantage
due to insufﬁcient stability, and still require a technique for ob-
taining a blood sample (Vashist et al., 2011). It seems that a glucose
sensor that does not require the use of enzymes, exhibits good
stability, and can be reused is far from being practical because it
requires the use of recent advanced fabrication processes (Kaimori
et al., 2006).
The radio frequency (RF) detection method is one of the pro-
spective candidates for the basis of a glucose sensor out of several
detection methods available (Lee et al., 2011). RF technology can
be applied to measure the characteristics of glucose by either a
direct or combination method. The RF sensing technique is a good
candidate for various types of biosensing applications such as DNA
hybridisation, binding of biotin and streptavidin, and metamaterial
and microwave glucose sensing (Lee et al., 2010; Spada et al.,
2011). In this work, a label-free minimally invasive rectangular
meandered line (RML) resonator functioning at a microwave fre-
quency of 9.20 GHz was analysed for the detection of the glucose
level in human serum and compared with an aqueous solution of
deionised (D) water glucose solution (Kim et al., 2008). Glucose atnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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constants because the electrical properties depend upon the
concentration. The detection of the glucose levels is based on the
variation of the dielectric property with the different concentra-
tions of glucose present in the serum and the change in the
electrical behaviour due to the skin effect of the meandered con-
ductive line (Abdalla et al., 2010). To increase the sensitivity of the
resonator, an air-bridge structure is fabricated by using integrated
passive device (IPD) technology on the top metal layer, which
improves the sensitivity by increasing the magnitude of the return
loss (S21) by selective variation of bridge capacitance.
When an analyte is dropped onto the RF biosensor, changes
will occur due to inductive and capacitive effects, which produce
return losses and considerable shifts in the resonance frequency of
the device. In the air-bridge area of the biosensor, the capacitance
is proportional to the dielectric constant and the distance between
the lower and upper conductive surfaces. The analyte then causes
the change in the electrical behaviour of the biosensor mainly due
to the capacitive effect.2. Materials and methods
The ﬁrst random sample of serum was selected with a glucose
concentration ranging from 148 mg dl1 to 268 mg dl1 (sample
1), and a second random sample of serum was selected with a
glucose concentration ranging from 105 mg dl1 to 225 mg dl1
(sample 2) (Peng et al., 2013). The sample was prepared by cen-
trifugation at 3000 rpm for 12 min in the laboratory (Department
of Biochemistry and Molecular biology, Medical College, Kyung
Hee University, Seoul, S. Korea), separating whole blood into red
blood cells (on the bottom) and serum (on the top of the test tube).
Thus, the glucose concentration in the obtained serum was varied
at a 20 mg dl1 interval for seven different samples. At the same
time, we also prepared an aqueous D-glucose solution with con-
centrations ranging from 25 mg dl1 to 500 mg dl1. The data
obtained from the D-glucose solution were then compared with
the data obtained from the serum to determine relative shift in the
resonance frequency.
2.1. Analytical process
The ﬁrst step in the analytical development of a microwave
resonator as a minimally invasive biosensor was performed using
the electromagnetic simulation SONNET as shown in Fig. 1A. A
sampled model of glucose (Fig. 1B) at different concentrations
(from 25 mg dl1 to 500 mg dl1) with a volume of 1-μl was
implemented, which can create a reasonable shift in the resonance
frequency for different concentrations. Next, for comparative
analysis between the D-glucose and serum glucose levels, the
process was again performed for two different samples of serum,
with concentrations ranging from 148–268 mg dl1 and
105–225 mg dl1, respectively. The experimental results for the
transmission parameter (S21) were obtained using an Agilent
8510C vector network analyser (VNA), and other decomposition
parameters from the measurements were generated for further
veriﬁcation. The top surface of the chip was coated with Au to
avoid unnecessary reaction, and the surface roughness was im-
proved via an etching process to avoid the unnecessary loss of
signal due to the skin effect, which improved the transmission
parameter by minimising the signal loss.
The best surface morphological structures were generated after
the physical plasma etching process with a root mean square
(RMS) value of 63.66 nm. The parameters used for etching are as
follows: an RF generator power of 150 W, an inductive coupled
plasma (ICP) power of 1000 W, a total gas pressure of 7.5 mTorr,and a chamber temperature of 293 K. The resonator had total di-
mensions of 2 mm by 1.16 mm with a mounted air-bridge struc-
ture, used to provide increased sensitivity by improving the ca-
pacitive effect, on the surface of the chip. The input transmission
line starts at the input ports, develops its meandered line struc-
ture, and ends on the opposite side. The device behaviour can be
understood as a resonator for which the transmission parameters
are affected by a top layer of different materials with a different
dielectric constants; such a device ultimately helps in diagnosing
the level of glucose in diabetes patients through the analysis of the
serum.2.2. Device concept and fabrication
The fabrication of the device started with the silicon nitride
(SiNx, 200 nm) passivation layer, which was ﬁrst deposited over a
gallium arsenide (GaAs, 400 μm) substrate using plasma enhanced
chemical vapour deposition (PECVD). Next, a 2 μm-thick Au metal
layer was formed by electroplating, which was used to form the
metal lines for the meandered line structure of the resonator.
Subsequently, a 20/80 nm Ti/Au seed metal was deposited by a RF
sputtering process. The passivation layer is necessary to attain an
even surface over any defects or roughness on the substrate sur-
face. The passivation layer enhances the adhesion between the
substrate and the ﬁrst metal layer. Again, a seed metal layer was
formed as previously described, followed by a second passivation
layer of 200-nm SiNx deposited via PECVD to prevent a possible
electrical shortage between the ﬁrst and second metal layers. Next,
an air-bridge photo-process was performed prior to the Au (3 mm)
air-bridge metal deﬁnition and plating process, by which the air-
bridge interconnections were formed at broken coil paths around
the metal beeline for the resonator, as shown in Fig. 1C. After the
electroplating process, the air-bridge mask was stripped, and re-
active ion etching of the Ti/Au seed metal was performed. The ﬁnal
fabricated device with an air-bridge structure is shown in Fig. 1C
(Wang et al., 2011, 2010).
To analyse the application of the biosensor to real world si-
tuations, it was exposed to human serum from two different
subjects with different concentration of glucose. The concentra-
tions ranged from 148 to 268 mg dl1 for the ﬁrst sample and
from 105–225 mg dl1 for the second sample. The equivalent cir-
cuit modelling the entire process is shown in Fig. 1D, which con-
sists of a parallel LC circuit, where L, Cg, and Ca represent the in-
ductance of the meandered line, the capacitive component be-
tween the ground and the signal line, and the bridge capacitance
formed by the glucose solution or the serum, respectively, as il-
lustrated in Fig. 1E. The resonance frequency is described by
Π=f LC1/2 (1)a
where the bridge capacitance (Ca) depends on the concentration of
glucose because of the dependence of the dielectric constant on
the glucose concentration. The Ca shown in Fig. 1D has a different
value for the different solutions and ultimately generates the
different resonance frequencies of the sensor characterised by
Eq. (1) (Ahmadi and Jullien, 2009). The change in the electrical
behaviour was caused by the concentration of electrons (e) on
the outer surface of the resonator due to the inductive force, as
illustrated in Fig. 1A. The RF biosensor was operating at a high
operating frequency at an X-band of 9.20 GHz. Therefore, the
electrons (e) are concentrated on the outer surface of the
meandered conductive line and effectively generate a return loss
and insertion loss that varies with the use of various glucose levels
in serum, even for a minimum level of glucose.
Fig. 1. Conception of serum glucose level detection using an RF resonator as a biosensor. (A) The current density showing the ﬂow of current at the outer surface of the air-
bridge structure measured at 9.20 GHz using the EM Simulator SONNET. (B) The sensitive part of the air bridge structure with bridge capacitance (Ca). (C) Fabrication of the
biosensor with the IPD process. (D) The equivalent circuit model involving R, L, and C of the ports, after the serumwas dropped on the biosensor. (E) The air-bridge structure
by IPD.
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The RF detection of the glucose level is based on the resonance
concept of the resonator. The biosensor produced a reasonable
shift in the resonance frequency as well as a variation in the am-
plitude of the signal. The principle relies on the detection of the
change in the RF signal caused by the volume of the analyte, which
determines the dielectric parameters of a glucose molecule on the
surface of the biosensor and is shown in Fig. 1D (Park et al., 2014;
Liao et al., 2003). As a result, the biosensor can accurately de-
monstrate the minimum value of the resonance shift for different
samples of the serum and the D-glucose solutions. The change inFig. 2. Schematic diagram of (A) the ﬁnal fabricated device packed in a printed circu
transmission line for measurement. (B) The measurement concept, after the use of seru
glucose level with the VNA. (D) Cross-section of the air-bridge structure. (E) Serum as a
490390 μm2 consisting of an air-bridge structure.the S21 parameter and resonance shift was found to be due to the
electromagnetic interaction between the biosensor and the glu-
cose with a different dielectric constant (Kuranov et al., 2007;
Venkatesh and Raghavan, 2004). Measurements of S21 and the
fractional change in the resonance frequency of the resonator were
monitored. We performed the experiment with 1-μl of D-glucose
at a starting concentration of 25 mg dl1 to analyse the resonance
condition and to determine the resonance frequency. The process
was further implemented with different concentrations of D-glu-
cose up to 500 mg dl1. When the bare chip was exposed to D-
glucose at different concentrations, due to the capacitive and in-
ductive effects between the meandered-lines, the ﬁrst resonanceit board (PCB) with a 50 Ω port connected on the input and output side to the
m as a test analyte. (C) The experimental setup for biosensor measurement of the
n analyte was dropped on the surface of the biosensor covering the Au surface of
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observed, as illustrated in Fig. 2A. The process was then executed
with other concentrations of D-glucose to determine their re-
spective resonance conditions.
After the ﬁrst measurement with D-glucose, the structure was
rinsed with a phosphate buffered saline solution (PBS) at pH¼7 and
deionised water. The nitrogen drying process was used before the
next sample containing a different glucose concentration was ana-
lysed. Next, a 1-μl volume of serum of different glucose concentration
were dropped by micro-pipette onto the surface of the resonator
within the 490 μm by 390 μm area, as shown in Fig. 2B. The mean-
dered-line structure contains a sensitive air-bridge structure with Au
on the top surface, which generates a capacitive effect between the
serum on the surface and above and below the air-bridge. Serum
containing a different glucose concentration corresponds to a differ-
ent dielectric property. This change in dielectric properties caused a
shift in the resonance frequency from its initial resonance frequency.
For the ﬁnal testing of the RML based biosensor, the sensor was
packed in a PCB with a 50 Ω port connected on the input and
output sides to the transmission-line. The ports were then con-
nected to the two ports VNA, as shown in Fig. 2C. Before the ﬁnal
test with human serum and D-glucose, the RF measurement for the
S21 characteristic of the resonator was obtained and called the bare
resonance frequency. Next, 1-μl of serum containing glucose from
the micro-pipette was dropped onto the air-bridge structure of the
resonator chip, as illustrated in Fig. 2D and E. The best frequency
response of the resonator was obtained by measuring the S21 and
the correlation between the shifts in the resonance frequencyFig. 3. Morphological analysis. (A) The 2-D view of the bare biosensor, 3-D surface pr
roughness (A.3). (B) The 2-D view of the biosensor with serum concentration of 148 mg
surface roughness (B.3) and (C) The 2-D view of the biosensor after test and washed w
surface roughness (C.3).(Tura et al., 2010). Subsequently, the device was again rinsed with
PBS, at pH¼7 and deionised water at an ambient temperature
(25 °C) to ensure the stability of the device. The S21 parameter for
the bare chip was again measured with no frequency shift, in-
dicating that the signal was generated by the speciﬁc concentra-
tion of glucose in the serum. The measured bare resonance fre-
quency after the test was found to exactly match the initial bare
resonance frequency of 9.20 GHz. This result conﬁrmed that the
proposed device can be reused many times after the initial use by
rinsing with PBS, which ensures the stability of the system.
To improve the conductivity on the resonator surface, we pro-
duced a pattern with the best surface morphological structure. Argon
(Ar) plasma was used to adjust the surface roughness via etching, as
shown in Fig. 3A. The top surface of the resonator plated with Au can
be effectively etched by the Ar plasma for the generation of good
surface morphological structure. Atomic force microscopy (AFM)
images of the surface morphology were obtained, which determined
that an RMS value of 63.66 nm was produced for 5 min of etching
time. This alteration of the surface roughness with plasma etching
treatment was performed to change the surface from a hydrophobic
to a hydrophilic surface to increase the immobilisation rate of the
glucose molecules and the resonance process.3. Result and discussion
An RML resonator based biosensor for the biological detection of
glucose levels in diabetes patients was demonstrated. The reusabilityoﬁle (A.1), RF measurement of the device (A.2) and line proﬁle graph for surface
dl1, 3-D surface proﬁle (B.1), RF measurement (B.2) and line proﬁle graph for the
ith PBS, 3-D surface proﬁle (C.1), RF measurement (C.2) and line proﬁle graph for
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istics and further supported by morphological analysis of a bare chip, a
chip with blood serum, and ﬁnally with a chip washed with PBS.
Basically, two featured frequencies were observed: (a) a bare chip
resonating at 9.20 GHz and (b) a chip after D-glucose or serum from
the diabetes patients with different concentrations was dropped. From
the two featured frequencies studied, we determine that we can ob-
tain a reasonable shift in the resonance frequency for different glucose
concentrations in the serum and D-glucose.
3.1. Reusability and surface characterisation
The reusability of the biosensor was characterised by measuring
the resonance frequency before and after the use of serum and the D-
glucose solution. We performed three different sets of experiments for
each concentration of serum and D-glucose solution to observe the
resonance frequency for each-iteration loop of the experiment. A total
of 21 different experiments for each sample of the serum were tested
and represented by the scatter plot, as shown in Fig. S1 (Supple-
mentary section). No device response deterioration was observed over
this long iteration of the measurement process. As a result, the relative
standard deviation (RSD) of less than 1% was observed for each con-
centration of serum samples and aqueous solution of D-glucose. The
observed data show no overlapping of the resonance frequency
among the concentrations for different sets of the experiment. This
observation validates that the proposed device can be reused many
times after the initial use by rinsing with PBS. The bare resonance
frequency from each set of experiments after rinsing was obtained at
9.20 GHz, which conﬁrms the stability and reusability of the system.
To further assist the reusability of the biosensor, an intensive
study with morphological analysis of the top sensing surface at a
concentration of 148 mg dl1 was performed for three consecutive
iterations for a single device (Xu et al., 2009). We produced a
pattern, with the best surface morphological structure with an
RMS value of 63.66 nm at 5 min etching time. The standard de-
viation (SD) for the bare biosensor, the biosensor with humanFig. 4. Variation in the resonance frequency with amplitude variation. (A) Aqueous D-g
148 mg dl1 and (C) Human serum (sample 2) with a base glucose concentration of 10serum, and the biosensor after cleaning was found to be 1.20, 1.92,
and 1.22, respectively. This result signiﬁes that the RMS values for
each experiment are very much correlated. Table S1 (Supple-
mentary section) indicates the clear variation of the RMS value for
different stages of the experiment. The value with the lowest RMS
was selected for further analysis. The 2-D and 3-D view of a bare
biosensor with an RMS value of 63.66 nm and resonance fre-
quency of 9.20 GHz are shown in Fig. 3A, A.1 and A.2. Next, the
chip exposed to human serum with the concentration of
148 mg dl1 resulted in a RMS value of 14.98 nm (Fig. 3B and B.1)
with a resonance frequency of 9.04 GHz (Fig 3B.2). From Fig. 3B, it
is clear that the deposition of blood particles creates uneven peaks
and valleys of the surface, resulting in a relatively even distribu-
tion on the surface with a minimum RMS value compared to the
bare device, as indicated by line proﬁle for the surface morphology
(Fig 3B.3). Next, the device was rinsed with PBS and dried by ni-
trogen gas. After the testing of the device, the obtained RMS value
of 66.46 nm (Fig. 3C and C.1) and resonance frequency of 9.20 GHz
(Fig. 3C.2) ensured the reusability of the device for the future use.
The surface roughness proﬁles, before (Fig. 3A.3) and after
(Fig. 3C.3) the test were concluded to be similar. The process fur-
ther veriﬁed that there is no chemical immobilisation involved,
which can alter the resonance frequency from returning to its
initial position (Park et al., 2006).
3.2. RF response of the device
The transmission parameters clearly reﬂect the electrical behaviour
of the device (Moore, 2009; Park et al., 2012). In this study, we mea-
sured the transmission parameter of a device for two different types of
subjects: human serum and D-glucose, as illustrated in Fig. 4. The
biosensor with the bare Au surface exhibiting the resonance at
9.20 GHz is called the bare resonance frequency. For all of the patterns,
the resonance peak shifts downward with decreasing amplitude with
an increase in the glucose concentration. The resonance frequency of
the D-glucose solution varied in the range from 8.68 to 9.12 GHz with alucose solution. (B) Human serum (sample 1) with base a glucose concentration of
5 mg dl1.
=⎡⎣ ⎤⎦Rfor serum (sample 1)Regression
0.9973 (3)
2
Fig. 5. Regression analysis for the shift in the resonance frequency with the error
bars for (A) human serum (sample 1) with a base glucose concentration of
148 mg dl1 and (B) human serum (sample 2) with a base glucose concentration of
105 mg dl1. The error bars indicate deviation of resonance peak for n¼7 (RSD
o1%).
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generated a maximum shift of 160MHz and 90MHz for the minimum
glucose levels of 148 mg dl1 and 105mg dl1 for serum samples
1 and 2 (Fig. 4B and C), respectively. The device exhibited good sen-
sitivity in detecting 1.08 MHz and 0.85 MHz changes for the corre-
sponding 1 mg dl1 changes in the glucose concentrations in serum
samples 1 and 2, respectively.
3.3. Effect of the measurement time
The sensitivity of the device is reﬂected by the time required for
the ﬁnal output. To analyse the effectiveness of the proposed bio-
sensor, we measured the response to D-glucose at different time in-
tervals, namely, one, two, three and four minutes, and obtained a
regression plot for the shift in resonance frequency, as shown in Fig.
S2 (Supplementary section). The time varying calibration curve is
generated by dropping 1-μl of D-glucose with a concentration ranging
from 25–500 mg dl1 for different time (t) intervals of up to four min
at an interval of one minute. The device exhibits a minimum shift of
0 MHz and maximum shift of 80 MHz for the measurement time
interval of four minutes and one minute, respectively, at a minimum
concentration of 25 mg dl1. The rapid response and excellent results
with a tolerable shift in the resonance frequency are obtained for the
measurement time interval of 60 s at a minimum glucose con-
centration of 25 mg dl1, which demonstrates the enhanced real-
time identiﬁcation of the glucose level.
3.4. Calibration curves for the analysis of serum and D-glucose
We investigated the effect of an aqueous solution of D-glucose and
blood serum on the resonance frequency of the device. To obtain the
optimised performance of the device, we conducted experiments with
different samples of serum as well as a D-glucose solution with dif-
ferent glucose concentrations. Three different measurements for the
two different serum samples and D-glucose solution were conducted.
Eq. (2) represents the regression line for the D-glucose solution with
the minimum shift of 80 MHz from the initial bare resonance fre-
quency, as represented in Fig. S3 (Supplementary section).
The calibration curve represented by Eqs. (3) and (4) were gen-
erated from two different human serum samples by dropping 1-μl of
serum with glucose concentrations in the range of 148–268mg dl1
and 105–225 mg dl1 (Fig. 5A and B), respectively. The regression
value of 0.9973 generated for serum sample 1 is higher than the re-
gression value of 0.9928 generated for serum sample 2. This small
inconsistency in the regression value (R2) for the serum sample was
caused by the uncertainties in the preparation of seven different
glucose concentration levels achieved from the standard addition
technique. Each concentration level was prepared from the real
sample of blood having unique base glucose concentration level.
Identical environment and criteria cannot be realised practically for
both the real samples, so that there was slightly variation in the re-
lative frequency shift and so to the correlation coefﬁcient. Both the
samples were prepared in the laboratory by the biological process in
which each samples were treated separately to prepare different
concentration levels of glucose.
The analysis indicated that the resonance approach of identifying
the glucose level can be applied to the serum for detection of the
glucose level. Table 1 summarises the resonance frequency variation
with different concentrations of D-glucose and blood serum. We ob-
tained a minimum shift of 80MHz in the resonance frequency for a
minimum D-glucose concentration of 25 mg dl1. A minimum shift of
0.4 MHz corresponding to a 1 mg dl1 change in the glucose level was
also obtained. The sensing limitation of our device, known as the limit
of detection (LOD) was calculated as 8.01 mg dl1 and 13.20 mg dl1
for serum samples 1 and 2, respectively. In addition, the limit of
quantisation (LOQ) was estimated to be 24.30 mg dl1 and40mg dl1 for serum samples 1 and 2, respectively. The nature of the
calibration curves and the data obtained from the frequency shifts
with an RSD of less than 1% for each sample of serum indicates a small
spread of the resonance frequencies for a particular concentration.
These results are outstanding compared to the results of other
methods having a response time of 15 min and values for the LOD of
25 mg dl1 (Mamdouh et al., 2014), 12.02 mg dl1 (Kim et al., 2013)
and 36.6 mg dl1 (Ruifen et al., 2012), suggesting that this approach
can be applied to distinguish the level of glucose in diabetes patients.
The comparative analysis based on the performance is summarised in
Table S2 (Supplementary section). The calibration curves for D-glucose
and human serum can be ﬁtted by the following equations:
= − × +
−
=
−
⎡⎣ ⎤⎦
Y X
D R
[GHz] 0.001 [mg dl ] 9.1673,
for aqueous solution of glucoseRegression
0.9857 (2)
1
1
2
= − × +−Y X[GHz] 0.002 [mg dl ] 9.3377,2 1
Table 1
Comparison of the glucose levels in a standard solution of D-glucose and in two different serum samples.
aS.N D-glucose Human serum
Concentration
(mg dl1)
bf1 (GHz) cRSD (%) Sample 1
concentration (mg dl1)
bf2
(GHz)
cRSD (%) Sample 2
concentration
(mg dl1)
bf3 (GHz) cRSD(%)
1 500 8.68 70.23 268 8.81 70.11 225 8.91 70.11
2 400 8.76 70.17 248 8.84 70.24 205 8.95 70.17
3 300 8.84 70.23 228 8.89 70.17 185 8.97 70.11
4 200 9.00 70.86 208 8.93 70.17 165 9.00 70.11
5 100 9.08 70.17 188 8.96 70.11 145 9.04 70.11
6 75 9.10 70.10 168 9.01 70.22 125 9.08 70.17
7 25 9.12 70.11 148 9.04 70.17 105 9.11 70.17
8 Bare test 9.20 0 Bare test 9.20 0 Bare test 9.20 0
a S.N denotes the serial number.
b f1, f2 and f3 denotes the resonance frequencies for the different cases.
c RSD denotes the relative standard deviation.
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=
−
⎡⎣ ⎤⎦
Y X
R
[GHz] 0.0017 [mg dl ] 9.2895,
for serum (sample 2)Regression
0.9928 (4)
3
1
2
4. Conclusion
A reusable robust RF biosensor with an IPD air-bridge type re-
sonator was fabricated on a GaAs substrate for testing the glucose level
in serum samples with base glucose concentrations of 148 mg dl1
and 105mg dl1. The serum (sample 1) with a glucose concentration
of 148 mg dl1 generated an LOD of 8.01 mg dl1 and an LOQ of
24.30 mg dl1 and the serum (sample 2) with a glucose concentration
of 105 mg dl1 generated an LOD of 13.20 mg dl1 and an LOQ of
40 mg dl1. The studied biosensor provided a rapid response for each
of the serum samples within the linear calibration ranges of
148–268mg dl1 and 105–225mg dl1, with correlation coefﬁcients
of 0.9973 and 0.9928, respectively. This ﬁnding indicated the devel-
opment of resonance-based sensing with the excellent sensitivity of
1.08 MHz and 0.85 MHz per 1 mg dl1 for samples 1 and 2, respec-
tively. For a glucose level between 25–500 mg dl1, the biosensor
exhibited outstanding characteristics with an observed shift of 80 MHz
for a minimum concentration of 25 mg dl1, which is a clear indica-
tion of the glucose level detection. Moreover, the morphological ana-
lysis of this RF biosensor validates the robust reusability for the real
time detection of the glucose level in the whole blood of diabetes
patients during the point of care testing.Acknowledgements
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